Next-Generation Pulmonary Therapies: Personalized Tablets as a Game Changer in Asthma Treatment

The third greatest cause of death worldwide is respiratory illness, which includes asthma and chronic obstructive pulmonary disease (COPD). Both adults and children can suffer from asthma, a chronic inflammatory illness that is characterized by reversible airway constriction and hyperresponsiveness. Prevalence rates are greater in metropolitan regions such as Delhi, Mumbai, and Kolkata (8-10%) than in rural areas (3-5%). Asthma is made worse by poor air quality, particularly during pollution surges; in Delhi, emergency visits increase by 50% during these months. Even though asthma is common, many patients-particularly in rural areas-do not obtain the right diagnosis or treatment, and only 40-50% of them utilize their inhalers as prescribed. According to a poll conducted in 2021, 60% of Indian asthma sufferers know very little about how to treat their illness. Potential remedies are provided by innovative dosage forms including orodispersible pills and personalized medications. Orodispersible tablets are particularly helpful for patients who have trouble swallowing or who need fast medication release since they dissolve swiftly in the mouth without the need for water. These dose forms are a viable alternative for the treatment of asthma and other chronic illnesses because they increase patient compliance and improve therapeutic results.